Full Text View
Tabular View
No Study Results Posted
Related Studies
Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study
The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2006 by Assaf-Harofeh Medical Center.
Recruitment status was  Active, not recruiting
Study NCT00443105   Information provided by Assaf-Harofeh Medical Center

First Received on March 2, 2007.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Allergic Conjunctivitis
Additional conditions recognized in this trial
Conjunctivitis
Conjunctivitis, Allergic
More general conditions related to this trial
Conjunctival Diseases
Eye Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Additional drug interventions recognized in this trial
Tacrolimus
More general drug interventions related to this trial
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Assaf-Harofeh Medical Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services